Novo Holdings A/S as of Sept. 30, 2017
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 17 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Inogen (INGN) | 43.9 | $338M | 3.5M | 95.10 | |
Acceleron Pharma | 7.5 | $58M | 1.6M | 37.32 | |
Dermira | 6.8 | $52M | 1.9M | 27.00 | |
Corvus Pharmaceuticals (CRVS) | 6.7 | $52M | 3.2M | 15.94 | |
Anaptysbio Inc Common (ANAB) | 5.4 | $42M | 1.2M | 34.95 | |
Akebia Therapeutics (AKBA) | 4.8 | $37M | 1.9M | 19.67 | |
Flexion Therapeutics | 4.7 | $36M | 1.5M | 24.18 | |
Ra Pharmaceuticals | 3.9 | $30M | 2.0M | 14.60 | |
Merus N V (MRUS) | 3.6 | $28M | 1.4M | 19.87 | |
Nabriva Therapeutics | 3.1 | $24M | 2.9M | 8.19 | |
Reata Pharmaceuticals Inc Cl A | 2.4 | $18M | 593k | 31.10 | |
Kalvista Pharmaceuticals (KALV) | 2.4 | $18M | 2.7M | 6.73 | |
Invuity | 1.6 | $12M | 1.4M | 8.90 | |
Verona Pharma Plc ads (VRNA) | 1.5 | $11M | 741k | 15.35 | |
Wright Medical Group Rtsn V | 0.9 | $7.2M | 4.6M | 1.55 | |
Crispr Therapeutics (CRSP) | 0.5 | $4.0M | 223k | 17.87 | |
Apollo Endosurgery | 0.2 | $1.3M | 275k | 4.68 |